Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Implementing Lung Cancer Screening Under Medicare

Implementing Lung Cancer Screening Under Medicare Opinion Editorials represent the opinions of the authors and JAMA EDITORIAL and not those of the American Medical Association. The Last Chance to Get It Right? Harold C. Sox, MD In 2010, the investigators of the randomized National Lung more smoking-related comorbid conditions. In a study based Screening Trial (NLST) reported that annual screening with on the National Inpatient Survey, the odds of in-hospital mor- low-dose computed tomography (CT) reduced lung cancer tality after lung cancer surgery were 1.6-fold higher in Medi- mortality by 20% compared care patients than in commercially insured patients. with screening with chest In the MEDCAC discussion, the effect of screening on lung Viewpoint page 1193 radiographs. Subsequently, cancer mortality in the group aged 65 years and older was said several clinical practice guide- to be statistically indistinguishable from that in the younger Related article page 1248 lines recommended annual than 65 population; however, this comparison was inconclu- screening, and many insur- sive because the NLST did not enroll enough patients to test ers agreed to cover screening. Most recently, the US Preven- the hypothesis that the 2 subgroups were different. tive Services Task Force (USPSTF) recommended annual TheMEDCACseemedtoconcludethatMedicare-agepatients screening for 55- to 80-year-old individuals http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Implementing Lung Cancer Screening Under Medicare

JAMA , Volume 312 (12) – Sep 24, 2014

Loading next page...
 
/lp/american-medical-association/implementing-lung-cancer-screening-under-medicare-MwdjXAa3RF

References (13)

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2014.12921
pmid
25247515
Publisher site
See Article on Publisher Site

Abstract

Opinion Editorials represent the opinions of the authors and JAMA EDITORIAL and not those of the American Medical Association. The Last Chance to Get It Right? Harold C. Sox, MD In 2010, the investigators of the randomized National Lung more smoking-related comorbid conditions. In a study based Screening Trial (NLST) reported that annual screening with on the National Inpatient Survey, the odds of in-hospital mor- low-dose computed tomography (CT) reduced lung cancer tality after lung cancer surgery were 1.6-fold higher in Medi- mortality by 20% compared care patients than in commercially insured patients. with screening with chest In the MEDCAC discussion, the effect of screening on lung Viewpoint page 1193 radiographs. Subsequently, cancer mortality in the group aged 65 years and older was said several clinical practice guide- to be statistically indistinguishable from that in the younger Related article page 1248 lines recommended annual than 65 population; however, this comparison was inconclu- screening, and many insur- sive because the NLST did not enroll enough patients to test ers agreed to cover screening. Most recently, the US Preven- the hypothesis that the 2 subgroups were different. tive Services Task Force (USPSTF) recommended annual TheMEDCACseemedtoconcludethatMedicare-agepatients screening for 55- to 80-year-old individuals

Journal

JAMAAmerican Medical Association

Published: Sep 24, 2014

There are no references for this article.